DIHUA YU to Tumor Microenvironment
This is a "connection" page, showing publications DIHUA YU has written about Tumor Microenvironment.
Connection Strength
1.235
-
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1. Cancer Cell. 2022 01 10; 40(1):36-52.e9.
Score: 0.362
-
Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021 05; 221:107753.
Score: 0.338
-
Brain Metastasis Organotropism. Cold Spring Harb Perspect Med. 2020 05 01; 10(5).
Score: 0.325
-
Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019 04; 1871(2):455-468.
Score: 0.076
-
Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer. Cancer Res. 2012 Sep 01; 72(17):4417-28.
Score: 0.047
-
Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation. Int J Biol Sci. 2023; 19(10):2957-2973.
Score: 0.025
-
Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion. Sci Adv. 2023 02 03; 9(5):eadd6995.
Score: 0.025
-
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression. Nat Immunol. 2019 07; 20(7):835-851.
Score: 0.019
-
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis. J Clin Invest. 2017 12 01; 127(12):4498-4515.
Score: 0.017